Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for ventricular arrhythmias in heart failure patients with an ICD
IRCT20120520009801N10Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) and ventricular arrhythmia (VA) comparing Dapagliflozin with Placebo control (2 arms). Primary endpoint: Frequency of ventricular arrhythmias. Started Jul 2023; status: completed.
02
Drugs
dapagliflozin
03
Conditions
heart failure (HF)ventricular arrhythmia (VA)
Beyond the preview
Go deeper on IRCT20120520009801N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120520009801N10.